Lorincz Z - Search Results

1

Toxicogenomics screening of small molecules using high-density, nanocapillary real-time PCR.

Vass L, Kelemen JZ, Fehér LZ, Lorincz Z, Kulin S, Cseh S, Dormán G, Puskás LG. Vass L, et al. Among authors: lorincz z. Int J Mol Med. 2009 Jan;23(1):65-74. Int J Mol Med. 2009. PMID: 19082508

2

Functional effects of domain deletions in a multidomain serine protease, C1r.

Cseh S, Gál P, Sárvári M, Dobó J, Lörincz Z, Schumaker VN, Závodszky P. Cseh S, et al. Among authors: lorincz z. Mol Immunol. 1996 Mar-Apr;33(4-5):351-9. doi: 10.1016/0161-5890(95)00160-3. Mol Immunol. 1996. PMID: 8676886

3

Isolation of human alpha 2HS-glycoprotein synthesized by Sf9 cells.

Lörincz Z, Kalabay L, Cseh S, Závodszky P, Arnaud P, Jakab L. Lörincz Z, et al. Acta Microbiol Immunol Hung. 1998;45(3-4):419-24. Acta Microbiol Immunol Hung. 1998. PMID: 9873947

4

One active C1r subunit is sufficient for the activity of the complement C1 complex: stabilization of C1r in the zymogen form by point mutations.

Dobó J, Gál P, Szilágyi K, Cseh S, Lörincz Z, Schumaker VN, Závodszky P. Dobó J, et al. Among authors: lorincz z. J Immunol. 1999 Jan 15;162(2):1108-12. J Immunol. 1999. PMID: 9916740

5

The cleavage of two C1s subunits by a single active C1r reveals substantial flexibility of the C1s-C1r-C1r-C1s tetramer in the C1 complex.

Lörincz Z, Gál P, Dobó J, Cseh S, Szilágyi K, Ambrus G, Závodszky P. Lörincz Z, et al. J Immunol. 2000 Aug 15;165(4):2048-51. doi: 10.4049/jimmunol.165.4.2048. J Immunol. 2000. PMID: 10925288

6

Recent advances in chemical genomics.

Darvas F, Dormán G, Krajcsi P, Puskás LG, Kovári Z, Lörincz Z, Urge L. Darvas F, et al. Among authors: lorincz z. Curr Med Chem. 2004 Dec;11(23):3119-45. doi: 10.2174/0929867043363848. Curr Med Chem. 2004. PMID: 15579004 Review.

7

[Comparative chemical proteomics: simultaneous identification of disease-specific protein targets and their small molecule-binding partners, suitable as drug candidates].

Dormán G, Puskás LG, Fehér LZ, Hackler L, Lorincz Z, Lang C, Urge L, Darvas F. Dormán G, et al. Among authors: lorincz z. Acta Pharm Hung. 2006;76(1):3-9. Acta Pharm Hung. 2006. PMID: 17094670 Hungarian.

8

Combining 2D and 3D in silico methods for rapid selection of potential PDE5 inhibitors from multimillion compounds' repositories: biological evaluation.

Tömöri T, Hajdú I, Barna L, Lorincz Z, Cseh S, Dormán G. Tömöri T, et al. Among authors: lorincz z. Mol Divers. 2012 Feb;16(1):59-72. doi: 10.1007/s11030-011-9335-0. Epub 2011 Sep 27. Mol Divers. 2012. PMID: 21947759

9

A chemocentric approach to the identification of cancer targets.

Flachner B, Lörincz Z, Carotti A, Nicolotti O, Kuchipudi P, Remez N, Sanz F, Tóvári J, Szabó MJ, Bertók B, Cseh S, Mestres J, Dormán G. Flachner B, et al. Among authors: lorincz z. PLoS One. 2012;7(4):e35582. doi: 10.1371/journal.pone.0035582. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558171 Free PMC article.

10

[Selection of a melanine concentrating hormone receptor-1 (MCHR1) antagonists' focused library and its biological screening with AequoScreen].

Flachner B, Hajdú I, Dobi K, Lorincz Z, Cseh S, Dormán G. Flachner B, et al. Among authors: lorincz z. Acta Pharm Hung. 2013;83(3):71-87. Acta Pharm Hung. 2013. PMID: 24369586 Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters